BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
Reprints
Opioid utilization in workers compensation continued to drop in 2021, but drugs that manage opioid use disorder saw an increase, according to a drug trends report released Tuesday by Enlyte Group LLC.
Based on all 2021 calendar-year retail and mail-order transactions billed through the company’s pharmacy benefit management program, utilization of opioids decreased by 3.1% per claim, but medications that manage opioid withdrawal symptoms rose 7.4%.
Overall, prescription trends saw slight increases in 2021: 0.2% utilization per claim; 1.3% cost per claim; 1.1% cost per prescription, according to the report.
The report also found that six of the top 10 therapeutic classes experienced increased utilization per claim; however, none of the classes rose by more than 10%. The largest utilization increases were within the hematological and respiratory classes at 9.7% and 7.7%, respectively.
The use of opioid alternatives also saw increases: 3.3% more antidepressants and 2.3% more anticonvulsants.
1. Zurich ordered to pay $80 million in suit over employee incentives
3. Marsh McLennan sees rate hikes slowing; reports revenue growth
4. Travelers sees rate hikes continue; Q1 profit up over 15%
5. DeSantis signs legislation prohibiting local workplace heat protections
6. AI not a ‘substitute,’ but can benefit insurance industry: Experts